There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The optimal immunosuppression regimen for elderly kidney transplant recipients is
poorly defined. We sought to evaluate the short-term efficacy and safety of thymoglobulin
in geriatric recipients of deceased-donor kidneys.